This article is more than 5 years old. Information may no longer be current.

Sonoma issued FDA clearance for ankle fracture offering

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Sonoma recently announced they have received FDA 510(k) clearance for their FibuLock Nail ankle fracture fixation offering.

An intramedullary device, the FibuLock Nail is reportedly able to treat all fractures indicated for plate-based fixation while being less-invasive and allowing for anatomic ligament stabilization. The device is implanted into the fibula via an incision of under an inch in length and then stabilized via the device’s anchors.

The company is planning on introducing the FibuLock Nail in select markets during the second quarter of 2015.

"Until the FibuLock, there wasn't a device that could deliver the stability, versatility and effectiveness of plates,” stated Rick Epstein, chief executive officer of Sonoma, in a company release. “Now, our technology will allow surgeons to bring the advantages of nailing to ankle fracture patients."

Reference: http://www.sonomaorthopedics.com/